Detalhe da pesquisa
1.
Pre-treatment tumour perfusion parameters and initial RECIST response do not predict long-term survival outcomes for patients with head and neck squamous cell carcinoma treated with induction chemotherapy.
PLoS One
; 13(3): e0194841, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29590180
2.
Tumor plasma flow determined by dynamic contrast-enhanced MRI predicts response to induction chemotherapy in head and neck cancer.
Oral Oncol
; 51(5): 508-13, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25700703
3.
Dynamic contrast-enhanced MRI in patients with muscle-invasive transitional cell carcinoma of the bladder can distinguish between residual tumour and post-chemotherapy effect.
Eur J Radiol
; 82(12): 2161-8, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24034835
4.
Perfusion estimated with rapid dynamic contrast-enhanced magnetic resonance imaging correlates inversely with vascular endothelial growth factor expression and pimonidazole staining in head-and-neck cancer: a pilot study.
Int J Radiat Oncol Biol Phys
; 81(4): 1176-83, 2011 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21546171